Corporate action official notices

Delisting

Unlimited TURBO Put Warrant on DAX

DE000SV4CT61

Delisting

Unlimited TURBO Put Warrant on Euro Stoxx 50

DE000SV4EUA4

Delisting

19.00% p.a. Barrier Reverse Convertible on TUI

CH1248692761

Delisting

23.00% p.a. Barrier Reverse Convertible on Idorsia

CH1248692753

Delisting

24.00% p.a. Barrier Reverse Convertible on Varta

CH1248692746

Delisting

COOPER COS INC/THE REGISTERED SHARES DL -,10

US2166484020

Delisting

Leonteq Securities AG - Early Redemption

CH1292085151

Reason for the redemption: Issuer call Effective from: 26 February 2024 Publication as of: 27 February 2024

Listing

Listing of Exchange Traded Product on Adaptivv Downside Control Bitcoin ETF Index

CH1314031258

Issuer: Leonteq Securities AG, Guernsey Branch, St Peter Port, Guernsey Security description/name: Exchange Traded Product on Adaptivv Downside Control Bitcoin ETF Index Swiss Security number: 131403125 ISIN: CH1314031258 BX Symbol: ADBI Issue Size:1'000'000 Products Currency: USD Regulatory standard: The listing for the above-mentioned product has been applied for in accordance with the Additional Rules for the Listing of Exchange Traded Products on BX Swiss (Exchange Traded Product - ETP). Nature and brief description of the transaction: The Product is an Exchange Traded Product, which is issued as a SIX Triparty Collateral Management (“TCM”) Product and collateralized in accordance with the terms for TCM Products pursuant to the TCM Security Agreement and subject to compliance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Collateral Provider has entered into the TCM Security Agreement with SIX Repo AG as Collateral Agent and SIX SIS AG as depository and triparty collateral manager. The Collateral Provider will provide the collateral to secure the value of TCM Products, whereby such collateral can consist, among others, of the securities that are the direct or indirect underlying’s of the TCM Product but being in accordance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Product is issued under the Issuer’s base prospectus dated 21 September 2023 and the performance of the Product is linked to the Adaptivv Downside Control Bitcoin ETF Index (the “Underlying”). The Product is a Swiss Uncertificated Security under Swiss law. During the whole term of this Product, further information with regards to the Underlying, the TCM Security Agreement and the relevant product documentation can be ordered free of charge from the Lead Manager. Trades in the above-mentioned Exchange Traded Product (ETP) will not be “CCP-eligible”. On the contrary to other products in the Exchange Traded Products segment on BX Swiss trades will be instructed for bilateral settlement (excluding the CCP). This Product is a derivative instrument according to Swiss law. It does not qualify as unit of a collective investment scheme pursuant to article 7 et seqq. of the Swiss Federal Act on Collective Investment Schemes ("CISA") and is therefore neither registered nor supervised by the Swiss Financial Market Supervisory Authority FINMA. Investors do not benefit from the specific investor protection provided under the CISA. The First Exchange Trading Date of the Product is on 26.02.2024. In addition, the Product is listed on SIX Swiss Exchange AG; traded on SIX Swiss Exchange – Exchange Traded Products (ETPs). Lead Manager: Leonteq Securities AG, Zurich, Switzerland Paying Agent: Leonteq Securities AG, Zurich, Switzerland Calculation Agent: Leonteq Securities AG, Zurich, Switzerland Collateral Provider: Leonteq Securities AG, Zurich, Switzerland Authorized Participant: Leonteq Securities AG, Zurich, Switzerland

Delisting

NANOSTRING TECHNOLOGIES INC REGISTERED SHARES DL -,0001

US63009R1095

Delisting

Short Mini Future auf Givaudan SA

CH1173488755

Corporate Action

Société Générale Effekten GmbH - Anpassung von Unlimited Faktor-Optionsscheinen auf Walmart, Inc.

DE000SB3XFV7, DE000SB3XHH2

Walmart, Inc. hat einen Aktiensplit (3-for-1 stock split) durchgeführt (Stichtag: 26. Februar 2024). Demzufolge wurden die Wertpapiere gemäß den jeweiligen Emissionsbedingungen mit Wirkung zum Stichtag wie folgt angepasst: Für die Berechnung des Kapitalwerts am Stichtag wurde gemäß den jeweiligen Emissionsbedingungen ein R-Faktor von 0,33333333 angewandt.

Other

Strike/Barrier Adjustment SG - 26.02.2024

The following strike/barrier adjustments were made:

Delisting

Zürcher Kantonalbank: Early Redemptions

CH1250738999, CH1250739005, CH1268364341, CH1268364358, CH1268365561, CH1268365579

The following instruments are subject to an early redemption: ISIN Product CH1250738999 ZKB Put Warrant on DAX Index CH1250739005 ZKB Put Warrant on DAX Index CH1268364341 ZKB Call Warrant on DAX Index CH1268364358 ZKB Call Warrant on DAX Index CH1268365561 ZKB Call Warrant on SMI Index CH1268365579 ZKB Call Warrant on SMI Index Reason for the redemption: Issuer call Effective from: 26 February 2024 Publication as of: 29 February 2024

Delisting

8.00% p.a. Barrier Reverse Convertible on Swiss Re

CH1171796662

Delisting

9.00% p.a. Barrier Reverse Convertible on Airbus

CH1283541238

Delisting

INVITAE CORP REGISTERED SHARES DL -,0001

US46185L1035

Delisting

SAFEGUARD SCIENTIFICS INC

US7864492076

Listing

Listing of Exchange Traded Product on Leonteq Alquant Dynamic Tech Equity Index

CH1314028841

The Product is an Exchange Traded Product, which is issued as a SIX Triparty Collateral Management (“TCM”) Product and collateralized in accordance with the terms for TCM Products pursuant to the TCM Security Agreement and subject to compliance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Collateral Provider has entered into the TCM Security Agreement with SIX Repo AG as Collateral Agent and SIX SIS AG as depository and triparty collateral manager. The Collateral Provider will provide the collateral to secure the value of TCM Products, whereby such collateral can consist, among others, of the securities that are the direct or indirect underlying’s of the TCM Product but being in accordance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Product is issued under the Issuer’s base prospectus dated 21 September 2023 and the performance of the Product is linked to the Leonteq Alquant Dynamic Tech Equity Index (the “Underlying”). The Product is a Swiss Uncertificated Security under Swiss law. During the whole term of this Product, further information with regards to the Underlying, the TCM Security Agreement and the relevant product documentation can be ordered free of charge from the Lead Manager. Trades in the above-mentioned Exchange Traded Product (ETP) will not be “CCP-eligible”. On the contrary to other products in the Exchange Traded Products segment on BX Swiss trades will be instructed for bilateral settlement (excluding the CCP). This Product is a derivative instrument according to Swiss law. It does not qualify as unit of a collective investment scheme pursuant to article 7 et seqq. of the Swiss Federal Act on Collective Investment Schemes ("CISA") and is therefore neither registered nor supervised by the Swiss Financial Market Supervisory Authority FINMA. Investors do not benefit from the specific investor protection provided under the CISA. The First Exchange Trading Date of the Product is on 23.02.2024. In addition, the Product is listed on SIX Swiss Exchange AG; traded on SIX Swiss Exchange – Exchange Traded Products (ETPs). Lead Manager: Leonteq Securities AG, Zurich, Switzerland Paying Agent: Leonteq Securities AG, Zurich, Switzerland Calculation Agent: Leonteq Securities AG, Zurich, Switzerland Collateral Provider: Leonteq Securities AG, Zurich, Switzerland Authorized Participant: Leonteq Securities AG, Zurich, Switzerland

Listing

Listing of Exchange Traded Product on Leonteq Alquant Dynamic US Equity Index

CH1314028833

Issuer: Leonteq Securities AG, Guernsey Branch, St Peter Port, Guernsey Security description/name: Exchange Traded Product on Leonteq Alquant Dynamic US Equity Index Swiss Security number: 131402883 ISIN: CH1314028833 BX Symbol: AQUS Issue Size: 500'000 Products Currency: USD Regulatory standard: The listing for the above-mentioned product has been applied for in accordance with the Additional Rules for the Listing of Exchange Traded Products on BX Swiss (Exchange Traded Product - ETP). Nature and brief description of the transaction: The Product is an Exchange Traded Product, which is issued as a SIX Triparty Collateral Management (“TCM”) Product and collateralized in accordance with the terms for TCM Products pursuant to the TCM Security Agreement and subject to compliance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Collateral Provider has entered into the TCM Security Agreement with SIX Repo AG as Collateral Agent and SIX SIS AG as depository and triparty collateral manager. The Collateral Provider will provide the collateral to secure the value of TCM Products, whereby such collateral can consist, among others, of the securities that are the direct or indirect underlying’s of the TCM Product but being in accordance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Product is issued under the Issuer’s base prospectus dated 21 September 2023 and the performance of the Product is linked to the Leonteq Alquant Dynamic US Equity Index (the “Underlying”). The Product is a Swiss Uncertificated Security under Swiss law. During the whole term of this Product, further information with regards to the Underlying, the TCM Security Agreement and the relevant product documentation can be ordered free of charge from the Lead Manager. Trades in the above-mentioned Exchange Traded Product (ETP) will not be “CCP-eligible”. On the contrary to other products in the Exchange Traded Products segment on BX Swiss trades will be instructed for bilateral settlement (excluding the CCP). This Product is a derivative instrument according to Swiss law. It does not qualify as unit of a collective investment scheme pursuant to article 7 et seqq. of the Swiss Federal Act on Collective Investment Schemes ("CISA") and is therefore neither registered nor supervised by the Swiss Financial Market Supervisory Authority FINMA. Investors do not benefit from the specific investor protection provided under the CISA. The First Exchange Trading Date of the Product is on 23.02.2024. In addition, the Product is listed on SIX Swiss Exchange AG; traded on SIX Swiss Exchange – Exchange Traded Products (ETPs). Lead Manager: Leonteq Securities AG, Zurich, Switzerland Paying Agent: Leonteq Securities AG, Zurich, Switzerland Calculation Agent: Leonteq Securities AG, Zurich, Switzerland Collateral Provider: Leonteq Securities AG, Zurich, Switzerland Authorized Participant: Leonteq Securities AG, Zurich, Switzerland

Listing

Listing of Exchange Traded Product on Leonteq Alquant Long-Short US Equity Index

CH1314028858

Issuer: Leonteq Securities AG, Guernsey Branch, St Peter Port, Guernsey Security description/name: Exchange Traded Product on Leonteq Alquant Long-Short US Equity Index Swiss Security number: 131402885 ISIN: CH1314028858 BX Symbol: AQLS Issue Size: 500'000 Products Currency: USD Regulatory standard: The listing for the above-mentioned product has been applied for in accordance with the Additional Rules for the Listing of Exchange Traded Products on BX Swiss (Exchange Traded Product - ETP). Nature and brief description of the transaction: The Product is an Exchange Traded Product, which is issued as a SIX Triparty Collateral Management (“TCM”) Product and collateralized in accordance with the terms for TCM Products pursuant to the TCM Security Agreement and subject to compliance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Collateral Provider has entered into the TCM Security Agreement with SIX Repo AG as Collateral Agent and SIX SIS AG as depository and triparty collateral manager. The Collateral Provider will provide the collateral to secure the value of TCM Products, whereby such collateral can consist, among others, of the securities that are the direct or indirect underlying’s of the TCM Product but being in accordance with the Additional Rules for the Listing of Exchange Traded Products of BX Swiss. The Product is issued under the Issuer’s base prospectus dated 21 September 2023 and the performance of the Product is linked to the Leonteq Alquant Long-Short US Equity Index (the “Underlying”). The Product is a Swiss Uncertificated Security under Swiss law. During the whole term of this Product, further information with regards to the Underlying, the TCM Security Agreement and the relevant product documentation can be ordered free of charge from the Lead Manager. Trades in the above-mentioned Exchange Traded Product (ETP) will not be “CCP-eligible”. On the contrary to other products in the Exchange Traded Products segment on BX Swiss trades will be instructed for bilateral settlement (excluding the CCP). This Product is a derivative instrument according to Swiss law. It does not qualify as unit of a collective investment scheme pursuant to article 7 et seqq. of the Swiss Federal Act on Collective Investment Schemes ("CISA") and is therefore neither registered nor supervised by the Swiss Financial Market Supervisory Authority FINMA. Investors do not benefit from the specific investor protection provided under the CISA. The First Exchange Trading Date of the Product is on 23.02.2024. In addition, the Product is listed on SIX Swiss Exchange AG; traded on SIX Swiss Exchange – Exchange Traded Products (ETPs). Lead Manager: Leonteq Securities AG, Zurich, Switzerland Paying Agent: Leonteq Securities AG, Zurich, Switzerland Calculation Agent: Leonteq Securities AG, Zurich, Switzerland Collateral Provider: Leonteq Securities AG, Zurich, Switzerland Authorized Participant: Leonteq Securities AG, Zurich, Switzerland

Other

Strike/Barrier Adjustment SG - 23.02.2024

The following strike/barrier adjustments were made:

Delisting

Leonteq Securities AG: Early Redemptions

CH1292085383, CH1171796936, CH1171796944, CH1283543317

The following instruments are subject to an early redemption: ISIN CH1292085383 CH1171796936 CH1171796944 CH1283543317 Reason for the redemption: Issuer call Effective from: 22 February 2024 Publication as of: 23 February 2024

Other

Strike/Barrier Adjustments SG - 16.02.2024

The following strike/barrier adjustments were made:

Admission

Tracker Certificate on Hedera

CH1292088833

Admission

Tracker Certificate on Hedera

CH1292088841